The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
批准号:
10268221
负责人:
Elise N Erickson
金额:
$9.41万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-24 至 2022-07-31
关键词:
AccelerationAgeAge-YearsAgingAmericanBiologicalBiological AgingBiological MarkersBiological Specimen BanksBirthBloodBlood specimenCesarean sectionChildbirthChronologyClinical DataComplexDNADNA MethylationDataData SetEconomicsElderlyEnrollmentEnvironmentEnvironmental ExposureEpigenetic ProcessFetal TissuesFunctional disorderGene ExpressionGestational AgeGoalsHealthHigh Risk WomanImpairmentIndividualInduced LaborInfantKnowledgeLightLinkLongevityMaternal HealthMaternal MortalityMeasuresMediator of activation proteinMessenger RNAMethodsModelingModificationMorbidity - disease rateMothersMyometrialNational Institute of Child Health and Human DevelopmentNewborn InfantOutcomePatient Self-ReportPerinatal CarePersonal SatisfactionPersonsPhenotypePostpartum HemorrhagePregnancyPregnancy OutcomeProlonged laborProteinsPsychometricsPsychosocial StressResearchResearch MethodologyRoleSamplingSiteSocial EnvironmentSourceStressTestingTissue BanksTissuesTrainingUmbilical Cord BloodUnited StatesUterusWomanWorkadverse outcomeage groupage relatedbasecareer developmentchemical groupdata repositoryepigenetic markerexperiencefetalgenome wide association studygenome-widegenomic datahealth disparityhigh riskimprovedin uteroindexinginnovationmRNA Expressionmaternal morbiditymaternal outcomemethylation patternmortalitymyometriumnovel markerolder womenperinatal morbiditypredictive markerpsychosocialrepositorysexsocialsocioeconomicsstressortooluterine contractilityyoung woman
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Women of advanced age (> 35 years of age) are at significantly higher risk for adverse outcomes during
childbirth, compared to younger women. This problem is both critical and growing, as the number of births
occurring in this age group have increased nine-fold over the last 40 years, escalating maternal morbidity and
mortality in the US. Given that prolonged labor, Cesarean birth and postpartum hemorrhage are more common
among older women, a decline in uterine function (contractility) with advancing age may be a source of labor-
related dysfunction. Prior studies have shown that individuals’ biological ages often differ from chronological
(i.e. actual) ages, raising the possibility that biological age could be a better predictor of age-related perinatal
morbidity. A robust method of calculating biological age is the Epigenetic Clock, which determines an
individual’s Epigenetic Age based on their specific DNA methylation patterns (common epigenetic
modifications). Epigenetic Age has been shown to better predict morbidity or mortality over chronological age
and epigenetic aging is also associated with social adversity and stress exposure. Given that social and
economic stressors contribute to poor maternal outcomes (as evidenced by maternal health disparities), it is
possible that epigenetic age is also a key mediator of birth related morbidity. Therefore, I will test the central
hypothesis that epigenetic age will predict impaired uterine function more accurately than maternal
chronological age (years) and that greater epigenetic age is associated with higher indices of psychosocial/
socioeconomic stressors during pregnancy. The career development goal of this application is to gain
proficiency in genome wide epigenetic methods and epigenetic clock specifically in addition to expanding my
training to include health disparities research methods. In this proposal, I seek to integrate these scientific
fields and advance knowledge of the role of the environment on maternal health and morbidity related to
childbirth and uterine function. In the first aim, using bio-banked tissues, I will apply Epigenetic Clock methods
to extracted DNA from maternal uterine and blood samples to compare epigenetic age across tissue types and
correlate with uterine mRNA for proteins responsible for uterine contractility and function during labor. In the
second aim, I will use banked data and tissue from a large nationally representative sample of young (18-25
yo) and advanced age women (>35 yo). I will apply the Epigenetic Clock method to these DNA samples to 1)
understand the relationship between phenotypes of socioeconomic and psychosocial stress (using mixture
modeling) and epigenetic age in maternal blood and 2) examine the role of epigenetic age and uterine
dysfunction during labor leading to greater maternal morbidity (prolonged labor leading to cesarean delivery,
failed induction or postpartum hemorrhage). Finally, I will explore how maternal epigenetic age relates to
infants’ gestational age and his/her own epigenetic age. Together, this study will advance our knowledge of
how epigenetic aging can influence perinatal morbidity in the context of the maternal environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity
-
批准号:10750619
-
项目类别:
-
资助金额:$61.21万
-
财政年份:2023
-
负责人:Elise N Erickson
-
依托单位:
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
-
批准号:10630244
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Elise N Erickson
-
依托单位:
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
-
批准号:10599490
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Elise N Erickson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: